Skip to main content Accessibility help
×
×
Home

Measures of the DSM–5 mixed-features specifier of major depressive disorder

  • Mark Zimmerman (a1)

Abstract

During the past two decades, a number of studies have found that depressed patients frequently have manic symptoms intermixed with depressive symptoms. While the frequency of mixed syndromes are more common in bipolar than in unipolar depressives, mixed states are also common in patients with major depressive disorder. The admixture of symptoms may be evident when depressed patients present for treatment, or they may emerge during ongoing treatment. In some patients, treatment with antidepressant medication might precipitate the emergence of mixed states. It would therefore be useful to systematically inquire into the presence of manic/hypomanic symptoms in depressed patients. We can anticipate that increased attention will likely be given to mixed depression because of changes in the DSM–5. In the present article, I review instruments that have been utilized to assess the presence and severity of manic symptoms and therefore could be potentially used to identify the DSM–5 mixed-features specifier in depressed patients and to evaluate the course and outcome of treatment. In choosing which measure to use, clinicians and researchers should consider whether the measure assesses both depression and mania/hypomania, assesses all or only some of the DSM–5 criteria for the mixed-features specifier, or assesses manic/hypomanic symptoms that are not part of the DSM–5 definition. Feasibility, more so than reliability and validity, will likely determine whether these measures are incorporated into routine clinical practice.

Copyright

Corresponding author

*Address for correspondence: Mark Zimmerman, 146 West River Street; Providence, Rhode Island 02904, USA. (Email: mzimmerman@lifespan.org)

References

Hide All
1. Kraepelin, E. Manic-Depressive Insanity and Paranoia. Edinburgh: Livingstone; 1921.
2. Bauer, MS, Wisniewski, SR, Marangell, LB, et al. Are antidepressants associated with new-onset suicidality in bipolar disorder? A prospective study of participants in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP–BD). J Clin Psychiatry. 2006; 67(1): 4855.
3. Goldberg, JF, Perlis, RH, Bowden, CL, et al. Manic symptoms during depressive episodes in 1,380 patients with bipolar disorder: findings from the STEP–BD. Am J Psychiatry. 2009; 166(2): 173181. http://ajp.psychiatryonline.org/doi/pdf/10.1176/appi.ajp.2008.08050746.
4. Judd, LL, Schettler, PJ, Akiskal, H, et al. Prevalence and clinical significance of subsyndromal manic symptoms, including irritability and psychomotor agitation, during bipolar major depressive episodes. J Affect Disord. 2012; 138(3): 440448; Epub ahead of print Feb 6. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3677770/pdf/nihms468685.pdf.
5. Swann, AC, Moeller, FG, Steinberg, JL, Schneider, L, Barratt, ES, Dougherty, DM. Manic symptoms and impulsivity during bipolar depressive episodes. Bipolar Disord. 2007; 9(3): 206212. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2723749/pdf/nihms128564.pdf.
6. Dodd, S, Kulkarni, J, Berk, L, et al. A prospective study of the impact of subthreshold mixed states on the 24-month clinical outcomes of bipolar I disorder or schizoaffective disorder. J Affect Disord. 2010; 124(1–2): 2228. Epub ahead of print Nov 27, 2009.
7. Goldberg, J, Perlis, R, Ghaemi, S, et al. Adjunctive antidepressant use and symptomatic recovery among bipolar depressed patients with concomitant manic symptoms: findings from the STEP–BD. Am J Psychiatry. 2007; 164(9): 13481355. http://ajp.psychiatryonline.org/doi/pdf/10.1176/appi.ajp.2007.05122032.
8. Masi, G, Toni, C, Perugi, G, Mucci, M, Millepiedi, S, Akiskal, HS. Anxiety disorders in children and adolescents with bipolar disorder: a neglected comorbidity. Can J Psychiatry. 2001; 46(9): 797802.
9. Olgiati, P, Serretti, A, Colombo, C. Retrospective analysis of psychomotor agitation, hypomanic symptoms, and suicidal ideation in unipolar depression. Depress Anxiety. 2006; 23(7): 389397.
10. Perugi, G, Angst, J, Azorin, JM, et al. Mixed features in patients with a major depressive episode: the BRIDGE–II–MIX Study. J Clin Psychiatry. 2015; 76(3): e351e358.
11. Smith, DJ, Forty, L, Russell, E, et al. Sub-threshold manic symptoms in recurrent major depressive disorder are a marker for poor outcome. Acta Psychiatr Scand. 2009; 119(4): 325329. Epub ahead of print Dec 16, 2008.
12. Benazzi, F. Intra-episode hypomanic symptoms during major depression and their correlates. Psychiatry Clin Neurosci. 2004; 58(3): 289294 http://onlinelibrary.wiley.com/doi/10.1111/j.1440-1819.2004.01234.x/pdf.
13. Sato, T, Bottlender, R, Schroter, A, Möller, HJ. Frequency of manic symptoms during a depressive episode and unipolar “depressive mixed state” as bipolar spectrum. Acta Psychiatr Scand. 2003; 107(4): 268274.
14. Benazzi, F. Suicidal ideation and bipolar–II depression symptoms. Hum Psychopharmacol. 2005; 20(1): 2732.
15. Benazzi, F. Reviewing the diagnostic validity and utility of mixed depression (depressive mixed states). Eur Psychiatry. 2008; 23(1): 4048. Epub ahead of print Aug 30, 2007.
16. Koukopoulos, A, Sani, G, Koukopoulos, AE, Manfredi, G, Pacchiarotti, I, Girardi, P. Melancholia agitata and mixed depression. Acta Psychiatr Scand Suppl. 2007; 11(433): 5057. http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111/j.1600-0447.2007.00963.x,
17. Vieta, E. The treatment of mixed states and the risk of switching to depression. Eur Psychiatry. 2005; 20(2): 96100.
18. Perlis, RH, Cusin, C, Fava, M. Proposed DSM–5 mixed features are associated with greater likelihood of remission in out-patients with major depressive disorder. Psychol Med. 2014; 44(7): 13611367. Epub ahead of print Mar 15, 2012.
19. Benazzi, F. Bipolar disorder: focus on bipolar II disorder and mixed depression. Lancet. 2007; 369(9565): 935945.
20. Berk, M, Dodd, S, Malhi, GS. “Bipolar missed states”: the diagnosis and clinical salience of bipolar mixed states. Aust N Z J Psychiatry. 2005; 39(4): 215221.
21. Swann, AC, Lafer, B, Perugi, G, et al. Bipolar mixed states: an international society for bipolar disorders task force report of symptom structure, course of illness, and diagnosis. Am J Psychiatry. 2013; 170(1): 3142. http://ajp.psychiatryonline.org/doi/pdf/10.1176/appi.ajp.2012.12030301.
22. Koukopoulos, A, Sani, G, Ghaemi, SN. Mixed features of depression: why DSM–5 is wrong (and so was DSM–IV). Br J Psychiatry. 2013; 203(1): 35. http://bjp.rcpsych.org/content/203/1/3.long.
23. Malhi, GS, Das, P, Gessler, D, Outhred, T, Fritz, K. The mixed features of DSM–5. Aust N Z J Psychiatry. 2015; 49(9): 842843.
24. Koukopoulos, A, Sani, G. DSM–5 criteria for depression with mixed features: a farewell to mixed depression. Acta Psychiatr Scand. 2014; 129(1): 416. Epub ahead of print Apr 19, 2013.
25. Kim, W, Kim, H, Citrome, L, et al. More inclusive bipolar mixed depression definitions by requiring fewer non-overlapping mood elevation symptoms. Acta Psychiatr Scand. 2016; 134(3): 189198. Epub ahead of print May 2.
26. American Psychiatric Association. Practice Guideline for the Treatment of Patients with Major Depressive Disorder. 3rd ed. Washington, DC, American Psychiatric Association; 2010. https://psychiatryonline.org/pb/assets/raw/sitewide/practice_guidelines/guidelines/mdd.pdf.
27. Kroenke, K, Spitzer, R, Williams, J. The PHQ–9: validity of a brief depression severity measure. J Gen Intern Med. 2001; 16(9): 606613. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1495268/pdf/jgi_01114.pdf.
28. Rush, A, Trivedi, M, Ibrahim, H, et al. The 16-item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS–C), and self-report (QIDS–SR): a psychometric evaluation in patients with chronic major depression. Biol Psychiatry. 2003; 54(5): 573583.
29. Zimmerman, M, Chelminski, I, McGlinchey, JB, Posternak, MA. A clinically useful depression outcome scale. Compr Psychiatry. 2008; 49(2): 131140. Epub ahead of print Dec 20, 2007.
30. Ghaemi, SN, Boiman, EE, Goodwin, FK. Diagnosing bipolar disorder and the effect of antidepressants: a naturalistic study. J Clin Psychiatry. 2000; 61(10): 804808.
31. Ghaemi, SN, Ko, JY, Goodwin, FK. “Cade’s disease” and beyond: misdiagnosis, antidepressant use, and a proposed definition for bipolar spectrum disorder. Can J Psychiatry. 2002; 47(2): 125134.
32. Hantouche, EG, Akiskal, HS, Lancrenon, S, et al. Systematic clinical methodology for validating bipolar–II disorder: data in mid-stream from a French national multi-site study (EPIDEP). J Affect Disord. 1998; 50(2–3): 163173.
33. Birnbaum, HG, Shi, L, Dial, E, Oster, EF, Greenberg, PE, Mallett, DA. Economic consequences of not recognizing bipolar disorder patients: a cross-sectional descriptive analysis. J Clin Psychiatry. 2003; 64(10): 12011209.
34. Shi, L, Thiebaud, P, McCombs, JS. The impact of unrecognized bipolar disorders for patients treated for depression with antidepressants in the fee-for-services California Medicaid (Medi-Cal) program. J Affect Disord. 2004; 82(3): 373383.
35. Matza, LS, Rajagopalan, KS, Thompson, CL, de Lissovoy, G. Misdiagnosed patients with bipolar disorder: comorbidities, treatment patterns, and direct treatment costs. J Clin Psychiatry. 2005; 66(11): 14321440.
36. Depue, RA, Krauss, S, Spoont, MR, Arbisi, P. General Behavior Inventory identification of unipolar and bipolar affective conditions in a nonclinical university population. J Abnorm Psychol. 1989; 98(2): 117126.
37. Hirschfeld, R, Williams, J, Spitzer, R, et al. Development and validation of a screening instrument for bipolar spectrum disorder: The Mood Disorder Questionnaire. Am J Psychiatry. 2000; 157(11): 18731875. http://ajp.psychiatryonline.org/doi/pdf/10.1176/appi.ajp.157.11.1873.
38. Angst, J, Adolfsson, R, Benazzi, F, et al. The HCL–32: towards a self-assessment tool for hypomanic symptoms in outpatients. J Affect Disord. 2005; 88(2): 217233.
39. Ghaemi, SN, Miller, CJ, Berv, DA, Klugman, J, Rosenquist, KJ, Pies, RW. Sensitivity and specificity of a new bipolar spectrum diagnostic scale. J Affect Disord. 2005; 84(2–3): 273277.
40. Graham, RK, Parker, GB. The status of screening measures for bipolar disorder. Curr Opin Psychiatry. 2015; 28(1): 1823.
41. Wang, HR, Woo, YS, Ahn, HS, Ahn, IM, Kim, HJ, Bahk, WM. The validity of the Mood Disorder Questionnaire for screening bipolar disorder: a meta-analysis. Depress Anxiety. 2015; 32(7): 527538.
42. Zimmerman, M, Galione, J. Screening for bipolar disorder with the Mood Disorder Questionnaire: a review. Harv Rev Psychiatry. 2011; 19(5): 219228.
43. Rush, AJ, First, MB, Blacker, D. Handbook of Psychiatric Measures, 2nd ed. Washington, DC: American Psychiatric Association; 2008.
44. Altman, EG, Hedeker, D, Peterson, JL, Davis, JM. The Altman Self-Rating Mania Scale. Biol Psychiatry. 1997; 42(10): 948955.
45. Cooke, RG, Kruger, S, Shugar, G. Comparative evaluation of two self-report Mania Rating Scales. Biol Psychiatry. 1996; 40(4): 279283.
46. Braunig, P, Shugar, G, Kruger, S. An investigation of the Self-Report Manic Inventory as a diagnostic and severity scale for mania. Compr Psychiatry. 1996; 37(1): 5255.
47. Shugar, G, Schertzer, S, Toner, BB, DiGasbarro, I. Development, use, and factor analysis of a self-report inventory for mania. Compr Psychiatry. 1992; 33(5): 325331.
48. Bauer, MS, Crits-Christoph, P, Ball, WA, et al. Independent assessment of manic and depressive symptoms by self-rating: scale characteristics and implications for the study of mania. Arch Gen Psychiatry. 1991; 48(9): 807812.
49. Zimmerman, M, Chelminski, I, Young, D, Dalrymple, K, Martinez, JH. A clinically useful self-report measure of the DSM–5 mixed features specifier of major depressive disorder. J Affect Disord. 2014; 168(Oct): 357362. Epub ahead of print Jul 22.
50. Goodwin, F, Jamison, K. Manic-Depressive Illness: Bipolar Disorders and Recurrent Depression, 2nd ed. New York: Oxford University Press; 2007.
51. Vieta, E, Bobes, J, Ballesteros, J, et al. Validity and reliability of the Spanish versions of the Bech–Rafaelsen’s mania and melancholia scales for bipolar disorders. Acta Psychiatr Scand. 2008; 117(3): 207215. Epub ahead of print Dec 13, 2007.
52. Shansis, FM, Reche, M, Capp, E. Evaluating response to mood stabilizers in patients with mixed depression: a study of agreement between three different mania rating scales and a depression rating scale. J Affect Disord. 2016; 197: 17. Epub ahead of print Mar 3.
53. Young, RC, Biggs, JT, Ziegler, VE, Meyer, DA. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry. 1978; 133(5): 429435.
54. Bech, P. The Bech–Rafaelsen Mania Scale in clinical trials of therapies for bipolar disorder: a 20-year review of its use as an outcome measure. CNS Drugs. 2002; 16(1): 4763.
55. Altman, EG, Hedeker, DR, Janicak, PG, Peterson, JL, Davis, JM. The Clinician-Administered Rating Scale for Mania (CARS–M): development, reliability, and validity. Biol Psychiatry. 1994; 36(2): 124134.
56. Endicott, J, Spitzer, RL. A diagnostic interview: The Schedule for Affective Disorders and Schizophrenia. Arch Gen Psychiatry. 1978; 35(7): 837844.
57. Spitzer, RL, Endicott, J, Robins, E. Research diagnostic criteria: rationale and reliability. Arch Gen Psychiatry. 1978; 35(6): 773782.
58. Swann, AC, Steinberg, JL, Lijffijt, M, Moeller, GF. Continuum of depressive and manic mixed states in patients with bipolar disorder: quantitative measurement and clinical features. World Psychiatry. 2009; 8(3): 166172. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2758583/pdf/wpa030166.pdf.
59. Bowden, CL, Singh, V, Thompson, P, et al. Development of the Bipolar Inventory of Symptoms Scale. Acta Psychiatr Scand. 2007; 116(3): 189194.
60. Gonzalez, JM, Bowden, CL, Katz, MM, et al. Development of the Bipolar Inventory of Symptoms Scale: concurrent validity, discriminant validity and retest reliability. Int J Methods Psychiatr Res. 2008; 17(4): 198209.
61. First, MB, Spitzer, RL, Williams, JBW, Gibbon, M. Structured Clinical Interview for DSM–IV (SCID). Washington, DC: American Psychiatric Association; 1997.
62. Zimmerman, M, McGlinchey, JB, Chelminski, I. An inadequate community standard of care: lack of measurement of outcome when treating depression in clinical practice. Prim Psychiatry. 2008; 15: 6775.
63. Trivedi, M, Rush, A, Wisniewski, S, et al. Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D implications for clinical practice. Am J Psychiatry. 2006; 163(1): 2840. http://ajp.psychiatryonline.org/doi/pdf/10.1176/appi.ajp.163.1.28.
64. Akiskal, HS, Benazzi, F. Family history validation of the bipolar nature of depressive mixed states. J Affect Disord. 2003; 73(1–2): 113122.
65. Angst, J, Azorin, JM, Bowden, CL, et al. Prevalence and characteristics of undiagnosed bipolar disorders in patients with a major depressive episode: the BRIDGE Study. Arch Gen Psychiatry. 2011; 68(8): 791798. http://jamanetwork.com/journals/jamapsychiatry/fullarticle/1107421.
66. Benazzi, F, Akiskal, HS. Psychometric delineation of the most discriminant symptoms of depressive mixed states. Psychiatry Res. 2006; 141(1): 8188. Epub ahead of print Nov 28, 2005.
67. Serretti, A, Olgiati, P. Profiles of “manic” symptoms in bipolar I, bipolar II and major depressive disorders. J Affect Disord. 2005; 84(2–3): 159166.
68. Benazzi, F. Bipolar II depressive mixed state: finding a useful definition. Compr Psychiatry. 2003; 44(1): 2127.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

CNS Spectrums
  • ISSN: 1092-8529
  • EISSN: 2165-6509
  • URL: /core/journals/cns-spectrums
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Keywords

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed